Kromek Group PLC Capital Markets Day (0162O)
04 February 2016 - 6:00PM
UK Regulatory
TIDMKMK
RNS Number : 0162O
Kromek Group PLC
04 February 2016
4 February 2016
Kromek Group plc
("Kromek" or the "Company")
Capital Markets Day
Kromek (AIM: KMK), a radiation detection technology company
focusing on the medical, security and nuclear markets, is hosting a
Capital Markets Day, at its headquarters in Sedgefield, today.
The briefing will provide investors with an opportunity to
enhance their understanding of Kromek's business through a tour of
the manufacturing facility and a presentation will be given by the
senior management of the Company.
No material price-sensitive information will be disclosed and no
information relating to current trading will be provided.
Copies of the presentation will be made available on the Kromek
website: www.kromek.com.
Enquiries
Kromek Group plc
-------------------------------- ---------------
Arnab Basu, CEO +44 (0)1740
Derek Bulmer, CFO 626 060
-------------------------------- ---------------
Cenkos Securities plc
-------------------------------- ---------------
Bobbie Hilliam (NOMAD)
Julian Morse, Michael Johnson +44 (0)20 7397
(Sales) 8900
-------------------------------- ---------------
Luther Pendragon Ltd
-------------------------------- ---------------
Harry Chathli, Claire Norbury, +44 (0)20 7618
Alexis Gore 9100
-------------------------------- ---------------
About Kromek Group plc
Kromek Group plc is a UK technology company (global HQ in County
Durham) and a leading developer of high performance radiation
detection products based on cadmium zinc telluride ("CZT"). Using
its core CZT technology, Kromek designs develops and produces x-ray
and gamma ray imaging and radiation detection products for the
medical, security screening and nuclear markets.
The Group's products provide high resolution information on
material composition and structure and are used in multiple
applications, ranging from the identification of cancerous tissues
to hazardous materials, such as explosives, and the analysis of
radioactive materials.
The Group's business model provides a vertically integrated
technology offering to customers, from the growth of CZT crystals
to finished products or detectors, including software, electronics
and application specific integrated circuits ("ASICs").
The Group has operations in the UK, Germany and US (California
and Pennsylvania), and is selling internationally through a
combination of distributors and direct OEM sales.
Currently, the Group has over a hundred full time employees
across its global operations. Further information on Kromek Group
is available at www.kromek.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFXLLBQLFFBBV
(END) Dow Jones Newswires
February 04, 2016 02:00 ET (07:00 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Apr 2024 to May 2024
Kromek (LSE:KMK)
Historical Stock Chart
From May 2023 to May 2024